• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
alpha 1-Antitrypsin deficiency and susceptibility to lung disease.α1-抗胰蛋白酶缺乏症与肺部疾病易感性
Environ Health Perspect. 1979 Apr;29:57-61. doi: 10.1289/ehp.792957.
2
Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.α-1抗胰蛋白酶缺乏症在呼吸和肝脏并发症中的历史作用。
Gene. 2016 Sep 10;589(2):118-22. doi: 10.1016/j.gene.2016.01.004. Epub 2016 Jan 5.
3
alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants.α1-抗胰蛋白酶缺乏症与肺部疾病:职业性和环境性吸入物对风险的影响
Eur Respir J. 2005 Nov;26(5):909-17. doi: 10.1183/09031936.05.00021605.
4
Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).PiMM 表型患者与慢性阻塞性肺疾病(COPD)患者的功能特征与血清 α-1-抗胰蛋白酶(AAT)浓度的关系。
Eur J Intern Med. 2011 Dec;22(6):603-6. doi: 10.1016/j.ejim.2011.08.028. Epub 2011 Sep 29.
5
The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.蛋白酶、内质网应激和 SERPINA1 杂合性在肺部疾病和 α-1 抗胰蛋白酶缺乏症中的作用。
Expert Rev Respir Med. 2011 Jun;5(3):395-411. doi: 10.1586/ers.11.20.
6
Heritability of lung function in severe alpha-1 antitrypsin deficiency.严重α-1抗胰蛋白酶缺乏症患者肺功能的遗传度
Hum Hered. 2009;67(1):38-45. doi: 10.1159/000164397. Epub 2008 Oct 17.
7
Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.慢性阻塞性肺疾病患者的α-1 抗胰蛋白酶缺乏症:一项横断面研究。
Arch Bronconeumol. 2015 Nov;51(11):539-43. doi: 10.1016/j.arbres.2015.01.008. Epub 2015 Mar 21.
8
[Role of certain mechanisms in the pathogenesis of emphysema and a number of other lung diseases].[某些机制在肺气肿及其他多种肺部疾病发病机制中的作用]
Ter Arkh. 1985;57(3):144-8.
9
Alpha-1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):629-33. doi: 10.1016/j.bpg.2010.08.006.
10
Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.长效 α1-蛋白酶抑制剂治疗 COPD 合并 α1-抗胰蛋白酶缺乏症的长期临床结局:证据分析。
Respir Res. 2017 May 30;18(1):105. doi: 10.1186/s12931-017-0574-1.

本文引用的文献

1
Obstructive lung disease and alpha-1-antitrypsin deficiency gene heterozygosity.阻塞性肺病与α-1抗胰蛋白酶缺乏基因杂合性
Science. 1969 Aug 29;165(3896):899-901. doi: 10.1126/science.165.3896.899.
2
Genetic vs. quantitative analysis of serum alpha 1 -antitrypsin.血清α1-抗胰蛋白酶的基因分析与定量分析
N Engl J Med. 1972 Nov 23;287(21):1067-9. doi: 10.1056/NEJM197211232872104.
3
Serum trypsin inhibitory capacity and the idiopathic respiratory distress syndrome.血清胰蛋白酶抑制能力与特发性呼吸窘迫综合征
J Pediatr. 1972 Sep;81(3):588-92. doi: 10.1016/s0022-3476(72)80197-5.
4
Obstructive lung disease in heterozygotes for alpha-1 antitrypsin deficiency.α1抗胰蛋白酶缺乏症杂合子中的阻塞性肺疾病。
Ann Intern Med. 1974 Feb;80(2):209-12. doi: 10.7326/0003-4819-80-2-209.
5
Pathologic patterns of chronic obstructive pulmonary diseases in patients with normal and deficient levels of alpha 1 antitrypsin.α1抗胰蛋白酶水平正常和缺乏的慢性阻塞性肺疾病患者的病理模式
Am J Med. 1973 Jun;54(6):706-12. doi: 10.1016/0002-9343(73)90056-9.
6
Familial variation of leukocyte lysosomal protease and serum 1 -antitrypsin as determinants in chronic obstructive pulmonary disease.作为慢性阻塞性肺疾病决定因素的白细胞溶酶体蛋白酶和血清α1-抗胰蛋白酶的家族性变异。
Am Rev Respir Dis. 1973 May;107(5):718-27. doi: 10.1164/arrd.1973.107.5.718.
7
Cardiopulmonary function in 1 -antitrypsin heterozygotes exposed to severe air pollution.暴露于严重空气污染环境下的α1-抗胰蛋白酶杂合子的心肺功能。
Am Rev Respir Dis. 1973 Feb;107(2):289-91. doi: 10.1164/arrd.1973.107.2.289.
8
Enzymatic production of experimental emphysema in the dog. Route of exposure.犬实验性肺气肿的酶促产生。暴露途径。
Am Rev Respir Dis. 1974 Mar;109(3):351-7. doi: 10.1164/arrd.1974.109.3.351.
9
Interrelationships between the human alveolar macrophage and alpha-1-antitrypsin.人类肺泡巨噬细胞与α-1抗胰蛋白酶之间的相互关系。
J Clin Invest. 1973 Nov;52(11):2793-9. doi: 10.1172/JCI107475.
10
Serum alpha 1-antitrypsin variants. Prevalence and clinical spirometry.血清α1-抗胰蛋白酶变体。患病率及临床肺量计测定
Am Rev Respir Dis. 1973 Oct;108(4):918-25. doi: 10.1164/arrd.1973.108.4.918.

α1-抗胰蛋白酶缺乏症与肺部疾病易感性

alpha 1-Antitrypsin deficiency and susceptibility to lung disease.

作者信息

Evans H E, Bognacki N

出版信息

Environ Health Perspect. 1979 Apr;29:57-61. doi: 10.1289/ehp.792957.

DOI:10.1289/ehp.792957
PMID:315870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1637376/
Abstract

This subject concerns the complex interrelationship of a genetically determined protein deficiency, enzymes which are inhibited by that protein, environmental challenges such as cigarette smoke and industrial pollutants, and the occurrence of obstructive lung disease (Fig. 1). Unequivocal establishment of an etiological role for AAT deficiency, especially of intermediate degree, has proven to be difficult. Confounding variables such as enzyme concentration in PMN and PAMs, duration of exposure to potential environmental hazards, differences in laboratory methods utilized in measuring AAT and in studying pulmonary function all require investigation. The definitive study, incorporating all of these and other factors, has yet to be conducted. No single, clear-cut conclusion can be drawn from analysis of present studies. In those circumstances in which heterozygotes appear to be predisposed to COPD, phenotypic screening of the population at potential risk, such as industrial workers may be appropriate. Conversely, in conditions in which no association is demonstrated, such screening would not be justified. Perhaps, the best one can do is to suggest a "Scotch verdict"; that is, the issue of causation is not proven.

摘要

该主题涉及一种由基因决定的蛋白质缺乏、受该蛋白质抑制的酶、诸如香烟烟雾和工业污染物等环境挑战以及阻塞性肺病的发生之间的复杂相互关系(图1)。已证实明确确定α1抗胰蛋白酶(AAT)缺乏尤其是中度缺乏的病因学作用很困难。诸如中性粒细胞(PMN)和肺泡巨噬细胞(PAM)中的酶浓度、接触潜在环境危害的持续时间、测量AAT和研究肺功能所使用的实验室方法的差异等混杂变量都需要进行研究。纳入所有这些及其他因素的确定性研究尚未开展。对现有研究的分析无法得出单一、明确的结论。在杂合子似乎易患慢性阻塞性肺疾病(COPD)的情况下,对潜在风险人群如产业工人进行表型筛查可能是合适的。相反,在未证明存在关联的情况下,这种筛查是不合理的。也许,目前所能做的最好的就是给出一个“苏格兰裁决”;也就是说,因果关系问题尚未得到证实。